Cargando…
CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor
Lassa virus (LASV)—a member of the family Arenaviridae—causes Lassa fever in humans and is endemic in West Africa. Currently, no approved drugs are available. We screened 2480 small compounds for their potential antiviral activity using pseudotyped vesicular stomatitis virus harboring the LASV glyco...
Autores principales: | Takenaga, Toru, Zhang, Zihan, Muramoto, Yukiko, Fehling, Sarah Katharina, Hirabayashi, Ai, Takamatsu, Yuki, Kajikawa, Junichi, Miyamoto, Sho, Nakano, Masahiro, Urata, Shuzo, Groseth, Allison, Strecker, Thomas, Noda, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473031/ https://www.ncbi.nlm.nih.gov/pubmed/34578344 http://dx.doi.org/10.3390/v13091763 |
Ejemplares similares
-
Population Structure of Lassa Mammarenavirus in West Africa
por: Forni, Diego, et al.
Publicado: (2020) -
Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry
por: Tang, Ke, et al.
Publicado: (2020) -
Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library
por: Wang, Peilin, et al.
Publicado: (2018) -
Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
por: Rowaiye, Adekunle Babajide, et al.
Publicado: (2022) -
Screening of Botanical Drugs against Lassa Virus Entry
por: Liu, Yang, et al.
Publicado: (2021)